Last reviewed · How we verify

NCT03621579

Analysis of Retinal Nerve Fiber Layer and Macular Thickness After Congenital Cataract Surgery

Completed NA Last updated 8 August 2018
What this trial tests

NA trial testing cataract surgery in Congenital Cataract in 60 participants. Completed in 1 April 2018.

Timeline
1 March 2017
Primary endpoint
1 March 2018
1 April 2018

Quick facts

Lead sponsorWenzhou Medical University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment60
Start date1 March 2017
Primary completion1 March 2018
Estimated completion1 April 2018
Sites2 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Wenzhou Medical University

Who can join

Adults 1 Month to 12, any sex, with Congenital Cataract. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Congenital cataract is the main cause of form deprivation amblyopia in children. Current studies confirm that form deprivation amblyopia affects the retinal nerve fiber layer. However, there are different opinions about the effect of amblyopia on the optic nerve fiber thickness around the optic disc at home and abroad. Investigators have performed "cataract extraction with IOL implantation" on children with bilateral and unilateral congenital cataract. Investigators used OCT biometry to measure children's the retinal nerve fiber layer (RNFLT) and macular thickness (CMT) before and after surgery. Investigators dynamically observed changes in RNFL and CMT to explore the retinal mechanism of form deprivation amblyopia and help guide the clinical correct understanding of postoperative follow-up time.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of cataract surgery

Trials testing the same drug.

Other recruiting trials for Congenital Cataract

Currently open trials in the same condition.

Other Wenzhou Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03621579.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing